ProfileGDS5822 / ILMN_2688054
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 31% 26% 4% 11% 8% 37% 15% 18% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 115.631
GSM1276600PDAC Late Ablation Control 2
GSM1276601PDAC Late Ablation Control 38.526
GSM1276602PDAC Late Ablation 16.74
GSM1276603PDAC Late Ablation 2911
GSM1276604PDAC Late Ablation 37.18
GSM1303940PDAC Late Ablation_anti-CTLA4 117.537
GSM1303941PDAC Late Ablation_anti-CTLA4 2915
GSM1303942PDAC Late Ablation_anti-CTLA4 39.918